awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54339322-090942B5-AF77-4323-8F5A-E5BB5380BA1C
Q54339322-090942B5-AF77-4323-8F5A-E5BB5380BA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54339322-090942B5-AF77-4323-8F5A-E5BB5380BA1C
The gefitinib dose reduction on survival outcomes in epidermal growth factor receptor mutant non-small cell lung cancer.
P2860
Q54339322-090942B5-AF77-4323-8F5A-E5BB5380BA1C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54339322-090942B5-AF77-4323-8F5A-E5BB5380BA1C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b14d67294c11e7ecb9183dc68c6b69e3ec5844e5
P2860
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial